inTEST Reports Record Revenue of $30.8 Million and 16% Year-over-Year Growth in Net Income for Third Quarter 2022
- Second consecutive quarter of record revenue, up 46% year-over-year
- Organic revenue (non-GAAP)(1) increased 23% year-over-year
- Orders grew 55% year-over-year to
$32.7 million driven by acquisitions and strength in analog/mixed signal test and silicon carbide (SiC) production markets - Achieved second consecutive quarter of record backlog at
$47.9 million - Reported net income growth of 16% to
$2.5 million and diluted EPS up 15% to$0.23 year-over-year - Expects 2022 revenue at higher end of original range of
$110 million to$115 million despite continued headwinds from supply chain constraints and a strongU.S. dollar
inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing in key target markets which include automotive, defense/aerospace, industrial, life sciences, security, and semiconductor (“semi”), today announced financial results for the quarter ended
Third Quarter 2022 Review (see revenue by market and by segments in accompanying tables)
Three Months Ended | ||||||||||||||
($ in 000s) | Change | Change | ||||||||||||
$ | % | $ | % | |||||||||||
Revenue | 4.1% | 45.5% | ||||||||||||
Organic revenue (Non-GAAP) (1) | 6.8% | 23.0% | ||||||||||||
Gross profit | 2.6% | 33.7% | ||||||||||||
Gross margin | 45.2% | 45.8% | 49.2% | |||||||||||
Operating expenses (incl. intangible amort.) | -0.7% | 36.9% | ||||||||||||
Operating income | 15.8% | 23.9% | ||||||||||||
Operating margin | 10.3% | 9.2% | 12.2% | |||||||||||
Net earnings (GAAP) | 19.3% | 16.0% | ||||||||||||
Earnings per diluted share (“EPS”) (GAAP) | 15.0% | 15.0% | ||||||||||||
Adjusted net earnings (Non-GAAP) (1) | 10.9% | 21.6% | ||||||||||||
Adjusted EPS (Non-GAAP) (1) | 12.0% | 21.7% | ||||||||||||
Adjusted EBITDA (Non-GAAP) (1) | 6.2% | 31.4% | ||||||||||||
Adjusted EBITDA margin (Non-GAAP) (1) | 14.5% | 14.2% | 16.0% |
(1)Organic revenue, adjusted net earnings, adjusted EPS, adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures. Further information can be found under “Non-GAAP Financial Measures.” See also the reconciliations of GAAP financial measures to non-GAAP financial measures that accompany this press release. |
Compared with the prior-year period, revenue grew
Compared with the second quarter of 2022, sales to the semi market grew 17% with back-end strength serving the analog and mixed signal test market and continued front-end growth serving the SiC market. Sales increased 47% to the life sciences market and 35% to the defense market. The timing of projects resulted in a sequential decline in sales to the automotive/EV market when compared with an exceptionally strong second quarter.
The Company’s top five customers for the nine-month period represented approximately 30% of revenue, down from 35% in the prior-year period demonstrating the effect of the Company’s 5-Point Strategy to grow through diversification of customers, markets and geographies. Year to date, no single customer accounted for 10% or more of revenue.
Gross margin contracted slightly on a sequential basis primarily due to supply chain challenges, as well as product and channel mix.
Operating expenses were up
Balance Sheet and Cash Flow Review
Cash and cash equivalents (including restricted cash) and short-term investments at the end of the third quarter of 2022 were
Capital expenditures were
During the third quarter of 2022, the Company amended its loan agreement to expand the existing non-revolving delayed draw term loan facility by
Third Quarter 2022 Orders and Backlog (see orders by market in accompanying tables)
($ in 000s) | Three Months Ended | |||||||||||||
Change | Change | |||||||||||||
$ | % | $ | % | |||||||||||
Orders | 32,680 | 40,518 | (7,838) | -19.3% | 21,148 | 11,532 | 54.5% | |||||||
Backlog (at quarter end) | 47,890 | 45,981 | 1,909 | 4.2% | 20,428 | 27,642 | 134.4% |
Order growth of 54.5% over the prior-year period reflected increases across nearly all end markets especially in semi, defense and security. Orders for the semi market were up 44% to
For the third consecutive quarter, backlog reached another record of
Fourth Quarter Outlook and Guidance
Fourth quarter 2022 financial results are expected to be comparable with third quarter results. Revenue is expected to be in the range of
Fourth quarter operating expenses are expected to run at approximately
Fourth quarter 2022 EPS (GAAP) is expected to be in the range of
The foregoing guidance is based on management’s current views with respect to operating and market conditions and customers’ forecasts. It also assumes macroeconomic conditions remain unchanged through the end of the year. Actual results may differ materially from what is provided here today as a result of, among other things, the factors described under “Forward-Looking Statements” below. Further information about non-GAAP measures can be found under “Non-GAAP Financial Measures” and the reconciliations of GAAP financial measures to non-GAAP financial measures that accompany this press release.
Conference Call and Webcast
The Company will host a conference call and webcast today at
A telephonic replay will be available from
About inTEST Corporation
inTEST Corporation is a global supplier of innovative test and process solutions for use in manufacturing and testing in key target markets which include automotive, defense/aerospace, industrial, life sciences, and security, as well as both the front-end and back-end of the semiconductor manufacturing industry. Backed by decades of engineering expertise and a culture of operational excellence, inTEST solves difficult thermal, mechanical, and electronic challenges for customers worldwide while generating strong cash flow and profits. inTEST’s strategy leverages these strengths to grow organically and with acquisitions through the addition of innovative technologies, deeper and broader geographic reach, and market expansion. For more information, visit www.intest.com.
Non-GAAP Financial Measures
In addition to disclosing results that are determined in accordance with GAAP, we also disclose non-GAAP financial measures. These non-GAAP financial measures consist of organic revenue, adjusted net earnings (loss), adjusted earnings (loss) per diluted share, adjusted EBITDA, and adjusted EBITDA margin. Organic revenue is derived by excluding revenue generated by acquired businesses in the first twelve months of ownership from total revenue. Adjusted net earnings (loss) is derived by adding acquired intangible amortization, adjusted for the related income tax expense (benefit), to net earnings (loss). Adjusted earnings (loss) per diluted share is derived by dividing adjusted net earnings (loss) by diluted weighted average shares outstanding. Adjusted EBITDA is derived by adding acquired intangible amortization, interest expense, income tax expense, depreciation, and stock-based compensation expense to net earnings (loss). Adjusted EBITDA margin is derived by dividing adjusted EBITDA by revenue. These results are provided as a complement to the results provided in accordance with GAAP. Organic revenue is a non-GAAP financial measure presented to provide investors the understanding of the performance of the core business excluding the contributions of acquisitions in the first twelve months of ownership. Adjusted net earnings (loss) and adjusted earnings (loss) per diluted share are non-GAAP financial measures presented to provide investors with meaningful, supplemental information regarding our baseline performance before acquired intangible amortization charges as this expense may not be indicative of our underlying operating performance. Adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures presented primarily as a measure of liquidity as they exclude non-cash charges for acquired intangible amortization, depreciation and stock-based compensation. In addition, adjusted EBITDA and adjusted EBITDA margin also exclude the impact of interest income or expense and income tax expense or benefit, as these expenses may not be indicative of our underlying operating performance. The non-GAAP financial measures presented in this press release are used by management to make operational decisions, to forecast future operational results, and for comparison with our business plan, historical operating results and the operating results of our peers. Reconciliations from revenue to organic revenue, net earnings (loss) and earnings (loss) per diluted share to adjusted net earnings (loss) and adjusted earnings (loss) per diluted share and from net earnings (loss) to adjusted EBITDA and adjusted EBITDA margin, are contained in the tables below. The non-GAAP financial measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP financial measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements do not convey historical information but relate to predicted or potential future events and financial results, such as statements of the Company’s plans, strategies and intentions, or our future performance or goals, that are based upon management's current expectations. These forward-looking statements can often be identified by the use of forward-looking terminology such as “believes,” “expects,” “intends,” “may,” “will,” “should,” “plans,” “projects,” “forecasts,” “outlook,” “anticipates,” “targets,” “estimates,” or similar terminology. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.
Such risks and uncertainties include, but are not limited to, any mentioned in this press release as well as the Company’s ability to execute on its 5-Point Strategy, realize the potential benefits of acquisitions and successfully integrate any acquired operations, grow the Company’s presence in its key target and international markets, manage supply chain challenges, convert backlog to sales and to ship product in a timely manner; the success of the Company’s strategy to diversify its markets; the impact of inflation on the Company’s business and financial condition; the impact of the COVID-19 pandemic on the Company’s business, liquidity, financial condition and results of operations; indications of a change in the market cycles in the semi market or other markets served; changes in business conditions and general economic conditions both domestically and globally including rising interest rates and fluctuation in foreign currency exchange rates; changes in the demand for semiconductors; access to capital and the ability to borrow funds or raise capital to finance potential acquisitions or for working capital; changes in the rates and timing of capital expenditures by the Company’s customers; and other risk factors set forth from time to time in the Company’s
– FINANCIAL TABLES FOLLOW –
inTEST CORPORATION Consolidated Statements of Operations (In thousands, except share and per share data) (Unaudited) | |||||||||||||||
|
| Three Months Ended |
|
| Nine Months Ended | ||||||||||
|
| 2022 |
|
| 2021 |
|
| 2022 |
|
| 2021 | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
| $ | 30,771 |
|
| $ | 21,144 |
|
| $ | 84,423 |
|
| $ | 62,520 |
Cost of revenue |
|
| 16,873 |
|
|
| 10,749 |
|
|
| 45,964 |
|
|
| 31,642 |
Gross profit |
|
| 13,898 |
|
|
| 10,395 |
|
|
| 38,459 |
|
|
| 30,878 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling expense |
|
| 4,009 |
|
|
| 2,841 |
|
|
| 11,498 |
|
|
| 7,849 |
Engineering and product development expense |
|
| 1,866 |
|
|
| 1,334 |
|
|
| 5,649 |
|
|
| 4,012 |
General and administrative expense |
|
| 4,864 |
|
|
| 3,620 |
|
|
| 14,623 |
|
|
| 10,550 |
Restructuring and other charges |
|
| - |
|
|
| 51 |
|
|
| - |
|
|
| 303 |
Total operating expenses |
|
| 10,739 |
|
|
| 7,846 |
|
|
| 31,770 |
|
|
| 22,714 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
| 3,159 |
|
|
| 2,549 |
|
|
| 6,689 |
|
|
| 8,164 |
Other income (expense) |
|
| (120 | ) |
|
| (17 | ) |
|
| (425 | ) |
|
| 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings before income tax expense |
|
| 3,039 |
|
|
| 2,532 |
|
|
| 6,264 |
|
|
| 8,166 |
Income tax expense |
|
| 515 |
|
|
| 357 |
|
|
| 1,047 |
|
|
| 1,170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings |
| $ | 2,524 |
|
| $ | 2,175 |
|
| $ | 5,217 |
|
| $ | 6,996 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share - basic |
| $ | 0.24 |
|
| $ | 0.21 |
|
| $ | 0.49 |
|
| $ | 0.67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding - basic |
|
| 10,695,867 |
|
|
| 10,496,188 |
|
|
| 10,655,469 |
|
|
| 10,422,851 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share - diluted |
| $ | 0.23 |
|
| $ | 0.20 |
|
| $ | 0.48 |
|
| $ | 0.65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares and common share equivalents outstanding - diluted |
|
| 10,864,540 |
|
|
| 10,792,290 |
|
|
| 10,840,644 |
|
|
| 10,694,351 |
inTEST CORPORATION Consolidated Balance Sheets (In thousands) | ||||||||
|
|
|
|
| ||||
|
| 2022 |
|
| 2021 |
| ||
ASSETS |
| (Unaudited) |
|
|
|
|
| |
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
| $ | 8,901 |
|
| $ | 21,195 |
|
Restricted cash |
|
| 1,137 |
|
|
| - |
|
Short term investments |
|
| 3,494 |
|
|
| - |
|
Trade accounts receivable, net of allowance for doubtful accounts of |
|
| 21,134 |
|
|
| 16,536 |
|
Inventories |
|
| 21,092 |
|
|
| 12,863 |
|
Prepaid expenses and other current assets |
|
| 1,871 |
|
|
| 1,483 |
|
Total current assets |
|
| 57,629 |
|
|
| 52,077 |
|
Property and equipment: |
|
|
|
|
|
|
|
|
Machinery and equipment |
|
| 6,334 |
|
|
| 5,733 |
|
Leasehold improvements |
|
| 3,217 |
|
|
| 3,001 |
|
Gross property and equipment |
|
| 9,551 |
|
|
| 8,734 |
|
Less: accumulated depreciation |
|
| (6,482 | ) |
|
| (6,046 | ) |
Net property and equipment |
|
| 3,069 |
|
|
| 2,688 |
|
Right-of-use assets, net |
|
| 5,017 |
|
|
| 5,919 |
|
|
| 21,394 |
|
|
| 21,448 |
| |
Intangible assets, net |
|
| 18,894 |
|
|
| 21,634 |
|
Restricted certificates of deposit |
|
| 100 |
|
|
| 100 |
|
Other assets |
|
| 598 |
|
|
| 39 |
|
Total assets |
| $ | 106,701 |
|
| $ | 103,905 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Current portion of Term Note |
| $ | 4,100 |
|
| $ | 4,100 |
|
Current portion of operating lease liabilities |
|
| 1,430 |
|
|
| 1,371 |
|
Accounts payable |
|
| 8,183 |
|
|
| 4,281 |
|
Accrued wages and benefits |
|
| 3,537 |
|
|
| 4,080 |
|
Accrued professional fees |
|
| 886 |
|
|
| 1,048 |
|
Customer deposits and deferred revenue |
|
| 5,077 |
|
|
| 6,038 |
|
Accrued sales commissions |
|
| 1,164 |
|
|
| 863 |
|
Domestic and foreign income taxes payable |
|
| 1,335 |
|
|
| 2,024 |
|
Other current liabilities |
|
| 1,386 |
|
|
| 1,267 |
|
Total current liabilities |
|
| 27,098 |
|
|
| 25,072 |
|
Operating lease liabilities, net of current portion |
|
| 4,196 |
|
|
| 5,248 |
|
Term Note, net of current portion |
|
| 13,067 |
|
|
| 16,000 |
|
Deferred tax liabilities |
|
| 217 |
|
|
| 1,379 |
|
Contingent consideration |
|
| 1,238 |
|
|
| 930 |
|
Other liabilities |
|
| 464 |
|
|
| 453 |
|
Total liabilities |
|
| 46,280 |
|
|
| 49,082 |
|
Commitments and Contingencies |
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Preferred stock, |
|
| - |
|
|
| - |
|
Common stock, |
|
| 111 |
|
|
| 109 |
|
Additional paid-in capital |
|
| 31,516 |
|
|
| 29,931 |
|
Retained earnings |
|
| 29,610 |
|
|
| 24,393 |
|
Accumulated other comprehensive earnings (loss) |
|
| (602 | ) |
|
| 594 |
|
|
| (214 | ) |
|
| (204 | ) | |
Total stockholders' equity |
|
| 60,421 |
|
|
| 54,823 |
|
Total liabilities and stockholders' equity |
| $ | 106,701 |
|
| $ | 103,905 |
inTEST CORPORATION Consolidated Statements of Cash Flows (In thousands) (Unaudited) | |||||||
|
| Nine Months Ended | |||||
|
| 2022 |
|
| 2021 | ||
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
|
|
Net earnings |
| $ | 5,217 |
|
| $ | 6,996 |
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
Depreciation and amortization |
|
| 3,674 |
|
|
| 2,166 |
Provision for excess and obsolete inventory |
|
| 307 |
|
|
| 154 |
Foreign exchange loss |
|
| 107 |
|
|
| 36 |
Amortization of deferred compensation related to stock-based awards |
|
| 1,373 |
|
|
| 1,094 |
Discount on shares sold under Employee Stock Purchase Plan |
|
| 28 |
|
|
| - |
Loss on disposal of property and equipment |
|
| 45 |
|
|
| 20 |
Deferred income tax benefit |
|
| (1,162 | ) |
|
| (221) |
Changes in assets and liabilities: |
|
|
|
|
|
|
|
Trade accounts receivable |
|
| (4,900 | ) |
|
| (3,874) |
Inventories |
|
| (8,549 | ) |
|
| (2,051) |
Prepaid expenses and other current assets |
|
| (907 | ) |
|
| (26) |
Restricted certificates of deposit |
|
| - |
|
|
| 40 |
Other assets |
|
| (1 | ) |
|
| (10) |
Operating lease liabilities |
|
| (1,064 | ) |
|
| (918) |
Accounts payable |
|
| 3,947 |
|
|
| 1,425 |
Accrued wages and benefits |
|
| (527 | ) |
|
| 942 |
Accrued professional fees |
|
| (153 | ) |
|
| 52 |
Customer deposits and deferred revenue |
|
| (827 | ) |
|
| 1,697 |
Accrued sales commissions |
|
| 310 |
|
|
| 366 |
Domestic and foreign income taxes payable |
|
| (672 | ) |
|
| 302 |
Other current liabilities |
|
| 35 |
|
|
| (60) |
Other liabilities |
|
| 61 |
|
|
| (7) |
Net cash provided by (used in) operating activities |
|
| (3,658 | ) |
|
| 8,123 |
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
|
|
|
|
|
Refund of final working capital adjustment related to Acculogic |
|
| 371 |
|
|
| - |
Purchase of property and equipment |
|
| (1,043 | ) |
|
| (577) |
Purchase of short-term investments |
|
| (3,494 | ) |
|
| - |
Net cash used in investing activities |
|
| (4,166 | ) |
|
| (577) |
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
|
|
|
|
|
Repayments of Term Note |
|
| (2,933 | ) |
|
| - |
Proceeds from stock options exercised |
|
| 38 |
|
|
| 1,019 |
Proceeds from shares sold under Employee Stock Purchase Plan |
|
| 148 |
|
|
| - |
Shares redeemed into treasury stock |
|
| (10 | ) |
|
| - |
Net cash provided by (used in) financing activities |
|
| (2,757 | ) |
|
| 1,019 |
|
|
|
|
|
|
|
|
Effects of exchange rates on cash |
|
| (576 | ) |
|
| (99) |
|
|
|
|
|
|
|
|
Net cash provided by (used in) all activities |
|
| (11,157 | ) |
|
| 8,466 |
Cash, cash equivalents and restricted cash at beginning of period |
|
| 21,195 |
|
|
| 10,277 |
Cash, cash equivalents and restricted cash at end of period |
| $ | 10,038 |
|
| $ | 18,743 |
|
|
|
|
|
|
|
|
Cash payments for: |
|
|
|
|
|
|
|
Domestic and foreign income taxes |
| $ | 2,926 |
|
| $ | 1,053 |
inTEST CORPORATION Revenue by Market (In thousands) (Unaudited) | ||||||||||||||||||||||||||||||||
($ in 000s) | Three Months Ended | |||||||||||||||||||||||||||||||
Change | Change | |||||||||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||||
Revenue | ||||||||||||||||||||||||||||||||
Semi | $ | 19,170 | 62.3 | % | $ | 16,409 | 55.5 | % | $ | 2,761 |
| 16.8 | % | $ | 13,656 | 64.6 | % | $ | 5,514 |
| 40.4 | % | ||||||||||
Industrial |
| 2,130 | 6.9 | % |
| 2,930 | 9.9 | % |
| (800 | ) | -27.3 | % |
| 2,191 | 10.4 | % |
| (61 | ) | -2.8 | % | ||||||||||
Auto/EV |
| 1,621 | 5.3 | % |
| 3,594 | 12.2 | % |
| (1,973 | ) | -54.9 | % |
| 1,339 | 6.3 | % |
| 282 |
| 21.1 | % | ||||||||||
Life Sciences |
| 1,715 | 5.6 | % |
| 1,169 | 3.9 | % |
| 546 |
| 46.7 | % |
| 715 | 3.4 | % |
| 1,000 |
| 139.9 | % | ||||||||||
Defense/Aerospace |
| 1,914 | 6.2 | % |
| 1,423 | 4.8 | % |
| 491 |
| 34.5 | % |
| 947 | 4.5 | % |
| 967 |
| 102.1 | % | ||||||||||
Security |
| 871 | 2.8 | % |
| 794 | 2.7 | % |
| 77 |
| 9.7 | % |
| 6 | 0.0 | % |
| 865 |
| NM | |||||||||||
Other |
| 3,350 | 10.9 | % |
| 3,252 | 11.0 | % |
| 98 |
| 3.0 | % |
| 2,290 | 10.8 | % |
| 1,060 |
| 46.3 | % | ||||||||||
$ | 30,771 | 100.0 | % | $ | 29,571 | 100.0 | % | $ | 1,200 |
| 4.1 | % | $ | 21,144 | 100.00 | % | $ | 9,627 |
| 45.5 | % | |||||||||||
NM: not meaningful |
Orders by Market (In thousands) (Unaudited) | ||||||||||||||||||||||||||||||||
($ in 000s) | Three Months Ended | |||||||||||||||||||||||||||||||
Change | Change | |||||||||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||||
Orders | ||||||||||||||||||||||||||||||||
Semi | $ | 19,181 | 58.7 | % | $ | 26,732 | 66.0 | % | $ | (7,551 | ) | -28.2 | % | $ | 13.365 | 63.2 | % | $ | 5,816 |
| 43.5 | % | ||||||||||
Industrial |
| 2,309 | 7.1 | % |
| 2,366 | 5.8 | % |
| (57 | ) | -2.4 | % |
| 2,329 | 11.0 | % |
| (20 | ) | -0.9 | % | ||||||||||
Auto/EV |
| 2,870 | 8.8 | % |
| 2,750 | 6.8 | % |
| 120 |
| 4.4 | % |
| 2,161 | 10.2 | % |
| 709 |
| 32.8 | % | ||||||||||
Life Sciences |
| 927 | 2.8 | % |
| 1,535 | 3.8 | % |
| (608 | ) | -39.6 | % |
| 195 | 0.9 | % |
| 732 |
| 375.4 | % | ||||||||||
Defense/Aerospace |
| 3,149 | 9.6 | % |
| 1,897 | 4.7 | % |
| 1,252 |
| 66.0 | % |
| 1,174 | 5.6 | % |
| 1,975 |
| 168.2 | % | ||||||||||
Security |
| 1,072 | 3.3 | % |
| 989 | 2.4 | % |
| 83 |
| 8.4 | % |
| 71 | 0.3 | % |
| 1,001 |
| NM | |||||||||||
Other |
| 3,172 | 9.7 | % |
| 4,249 | 10.5 | % |
| (1,077 | ) | -25.3 | % |
| 1,853 | 8.8 | % |
| 1,319 |
| 71.2 | % | ||||||||||
$ | 32,680 | 100.0 | % | $ | 40,518 | 100.0 | % | $ | (7,838 | ) | -19.3 | % | $ | 21,148 | 100.0 | % | $ | 11,532 |
| 54.5 | % | |||||||||||
NM: not meaningful |
inTEST CORPORATION
Segment Data
(In thousands)
(Unaudited)
Beginning in the first quarter of 2022, the Company made a change to its reportable segments from two reportable segments to three reportable segments – Electronic Test, Environmental Technologies and Process Technologies. These segments, which operate as Divisions, align with how the Chief Executive Officer (CEO) who is also the Chief Operating Decision Maker (CODM) as defined under
| Three Months Ended |
|
| Nine Months Ended |
| ||||||||||
|
| 2022 |
|
|
| 2021 |
|
|
| 2022 |
|
|
| 2021 |
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
| ||||
Electronic Test | $ | 10,408 |
|
| $ | 8,103 |
|
| $ | 28,983 |
|
| $ | 25,658 |
|
Environmental Technologies |
| 7,631 |
|
|
| 6,875 |
|
|
| 22,131 |
|
|
| 19,720 |
|
Process Technologies |
| 12,732 |
|
|
| 6,166 |
|
|
| 33,309 |
|
|
| 17,142 |
|
Total Revenue | $ | 30,771 |
|
| $ | 21,144 |
|
| $ | 84,423 |
|
| $ | 62,520 |
|
Income from divisional operations: |
|
|
|
|
|
|
|
|
|
|
| ||||
Electronic Test | $ | 2,406 |
|
| $ | 2,364 |
|
| $ | 6,486 |
|
| $ | 8,858 |
|
Environmental Technologies |
| 1,021 |
|
|
| 1,090 |
|
|
| 2,893 |
|
|
| 3,126 |
|
Process Technologies |
| 2,465 |
|
|
| 1,078 |
|
|
| 5,764 |
|
|
| 2,695 |
|
Total income from divisional operations |
| 5,892 |
|
|
| 4,802 |
|
|
| 15,143 |
|
|
| 14,679 |
|
Corporate expenses |
| (2,138 | ) |
|
| (1,944 | ) |
|
| (6,312 | ) |
|
| (5,597 | ) |
Acquired intangible amortization |
| (595 | ) |
|
| (309 | ) |
|
| (2,142 | ) |
|
| (918 | ) |
Other income (expense) |
| (120 | ) |
|
| (17 | ) |
|
| (425 | ) |
|
| 2 |
|
Earnings before income tax expense | $ | 3,039 |
|
| $ | 2,532 |
|
| $ | 6,264 |
|
| $ | 8,166 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Non-GAAP Financial Measures (In thousands, except percentage data) (Unaudited) | ||||||||||||||||||||||||
| Three Months Ended | |||||||||||||||||||||||
|
|
| Change |
| Change | |||||||||||||||||||
| $ | % | $ | % | ||||||||||||||||||||
Total revenue (GAAP) | $ | 30,771 |
| $ | 29,571 |
| $ | 1,200 |
| 4.1 | % | $ | 21,144 | $ | 9,627 | 45.5 | % | |||||||
Less: Revenue from acquired businesses(2) |
| (4,754 | ) |
| (5,221 | ) |
| (467 | ) | -8.9 | % |
| - |
| 4,754 | NM |
| |||||||
Organic revenue (Non-GAAP) | $ | 26,017 |
| $ | 24,350 |
| $ | 1,667 |
| 6.8 | % | $ | 21,144 | $ | 4,873 | 23.0 | % |
| Nine Months Ended | |||||||||||||||||||||||
|
|
| Change | |||||||||||||||||||||
| $ | % | ||||||||||||||||||||||
Total revenue (GAAP) | $ | 84,423 |
| $ | 62,520 | $ | 21,903 | 35.0 | % | |||||||||||||||
Less: Revenue from acquired businesses(2) |
| (13,991 | ) |
| - |
| 13,991 | NM |
| |||||||||||||||
Organic revenue (Non-GAAP) | $ | 70,432 |
| $ | 62,520 | $ | 7,912 | 12.7 | % |
NM: not meaningful | ||
(2) | Acquired businesses consist of Acculogic ( |
inTEST CORPORATION Reconciliation of Non-GAAP Financial Measures (In thousands, except per share and percentage data) (Unaudited) | ||||||||||||
Reconciliation of Net Earnings (GAAP) to Adjusted Net Earnings (Non-GAAP) and | ||||||||||||
Earnings Per Share – Diluted (GAAP) to Adjusted Earnings Per Share – Diluted (Non-GAAP): | ||||||||||||
Three Months Ended | ||||||||||||
|
| |||||||||||
|
| |||||||||||
Net earnings (GAAP) | $ | 2,524 |
| $ | 2,175 |
| $ | 2,116 |
| |||
Acquired intangible amortization |
| 595 |
|
| 309 |
|
| 765 |
| |||
Tax adjustments |
| (103 | ) |
| (4 | ) |
| (162 | ) | |||
Adjusted net earnings (Non-GAAP) | $ | 3,016 |
| $ | 2,480 |
| $ | 2,719 |
| |||
Diluted weighted average shares outstanding |
| 10,865 |
|
| 10,792 |
|
| 10,815 |
| |||
Earnings per share – diluted: | ||||||||||||
Net earnings (GAAP) | $ | 0.23 |
| $ | 0.20 |
| $ | 0.20 |
| |||
Acquired intangible amortization |
| 0.06 |
|
| 0.03 |
|
| 0.07 |
| |||
Tax adjustments |
| (0.01 | ) |
| - |
|
| (0.02 | ) | |||
Adjusted earnings per share – diluted (Non-GAAP) | $ | 0.28 |
| $ | 0.23 |
| $ | 0.25 |
| |||
Reconciliation of Net Earnings (GAAP) to Adjusted EBITDA (Non-GAAP) and | ||||||||||||
Adjusted EBITDA Margin (Non-GAAP): | ||||||||||||
Three Months Ended | ||||||||||||
|
| |||||||||||
|
| |||||||||||
Net earnings (GAAP) | $ | 2,524 |
| $ | 2,175 |
| $ | 2,116 |
| |||
Acquired intangible amortization |
| 595 |
|
| 309 |
|
| 765 |
| |||
Interest expense |
| 166 |
|
| 4 |
|
| 133 |
| |||
Income tax expense |
| 515 |
|
| 357 |
|
| 454 |
| |||
Depreciation |
| 203 |
|
| 172 |
|
| 174 |
| |||
Non-cash stock-based compensation |
| 450 |
|
| 371 |
|
| 551 |
| |||
Adjusted EBITDA (Non-GAAP) | $ | 4,453 |
| $ | 3,388 |
| $ | 4,193 |
| |||
Revenue |
| 30,771 |
|
| 21,144 |
|
| 29,571 |
| |||
Adjusted EBITDA margin (Non-GAAP) |
| 14.5 | % |
| 16.0 | % |
| 14.2 | % | |||
Reconciliation of Fourth Quarter 2022 Estimated Earnings Per Share – Diluted (GAAP) to | ||||||||
Estimated Adjusted Earnings Per Share – Diluted (Non-GAAP): | ||||||||
| Low |
| High | |||||
|
|
|
| |||||
Estimated earnings per share – diluted (GAAP) | $ | 0.20 |
|
| $ | 0.25 |
| |
Estimated acquired intangible amortization |
| 0.06 |
|
|
| 0.06 |
| |
Estimated tax adjustments |
| (0.01 | ) |
|
| (0.01 | ) | |
Estimated adjusted earnings per share – diluted (Non-GAAP) | $ | 0.25 |
|
| $ | 0.30 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221104005156/en/
inTEST Corporation
Chief Financial Officer and Treasurer
Tel: (856) 505-8999
Investors:
dpawlowski@keiadvisors.com
Tel: (716) 843-3908
Source: inTEST Corporation